Claim Missing Document
Check
Articles

Found 2 Documents
Search

Interstitial lung disease in mixed connective tissue disease Tendean, Marshell; Nuriawan, Sazkia Aziza; Nugroho, Pringgodigdo
Indonesian Journal of Rheumatology Vol 9, No 1 (2017)
Publisher : Indonesian Rheumatology Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (640.147 KB)

Abstract

Interstitial lung diseases (ILD) are known as a debilitating pulmonary complications that may be occured in almost all systemic connective tissue diseases (CTD), including mixed connective tissue disease (MCTD). ILD is usually found in more than half of MCTD patients after 2-4years after the diagnosis made. A-47-years-old female initially diagnosed as systemic lupus erythematosus (SLE) developed a severe progressive dyspnea. She has recently diagnosed as MCTD with ILD after 9 months of initial symptoms. She was giving with Cyclophosphamide 500 mg IV pulse dose. However, after 1 months she developed severe pneumonia andpronounced demise due to intractable septic shock. The debilitating course of ILD is commonly seen in most systemic CTD. Therefore, it is important to perform initial screening and prevention. Systemic corticosteroid with or without immunosupressor agent(s) are indicated inILD-MCTD. Patients with progressive diseases will have poor prognosis.Keywords : ILD, MCTD, Corticosteroid
Overview of Patients with Hypertensive Heart Disease at the Cardiology Clinic of the Family Medical Center Hospital in 2020 Kurniadhi, Didi; Tendean, Marshell; Bernardi, Karek Roberto
Jurnal MedScientiae Vol 1 No 2 (2022): December
Publisher : Universitas Kristen Krida Wacana

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36452/JMedScientiae.v1i2.2946

Abstract

Hypertensive heart disease is a condition of changes in heart structure and function due to chronic hypertension, the term hypertensive heart disease ultimately includes conditions such as left ventricular hypertrophy, systolic heart failure, diastolic or both, irregular heartbeat and coronary heart disease. This study aims to describe the characteristics of patients with hypertensive heart disease such as sociodemographic descriptions such as age, gender, clinical manifestations, management including the type of drug given and the amount of drug given, as well as comorbidities in patients with hypertensive heart disease at the Cardiology Clinic of the Family Medical Center Hospital. 2020. The age group of patients with hypertensive heart disease is 56-65 years (36%), sex is dominated by women (55.8%), the majority of patients with hypertensive heart disease have clinical manifestations of LVH without heart failure (51.2%) , beta blockers were the most frequently administered drugs (72.2%), 3 types of drugs were the most frequently administered drugs to patients (33.8%), and diabetes was the most common comorbidity in patients (22.7%). Early screening and treatment of hypertension is very necessary to prevent the development of hypertension into hypertensive heart disease.